journal article·2026-06Open access

Poly(L-lactic-co-caprolactone)-nano hydroxyapatite promotes periodontal bone regeneration via mitochondrial metabolism-driven macrophage reprogramming

Pei Cao, Nan Li, Yuan-qing Liu, Yong Zhang, Pei-hui Zou, Jin Wu, Yu Cai, Chen-hao Yu, Liang Chen, Qing-xian Luan, Jia Liu

Nano Research· Volume 19· Issue 6

Abstract

Abstract Periodontitis, a chronic inflammatory disease causing progressive bone loss, demands biomaterials that simultaneously resolve inflammation and promote regeneration. Poly(L-lactic-co-caprolactone)-nano hydroxyapatite (PLCL-nHA) combines mechanical durability with bioactive potential, yet its precise immunomodulatory actions within inflammatory microenvironments remain unclear. This study demonstrates that PLCL-nHA restores periodontal homeostasis by suppressing inflammatory cascades and steering macrophage functional reprogramming. In a murine periodontitis model, PLCL-nHA implantation reduced alveolar bone resorption, altered the gingival microbiota profile (including reduction of Lactobacillus/Enterococcus), and suppressed osteoclastic activity. In vitro, PLCL-nHA suppressed LPS-induced pro-inflammatory cytokines and oxidative stress while promoting M2 macrophage polarization. Mechanistically, PLCL-nHA enhanced mitochondrial energy metabolism, which inhibited nuclear factor kappa B (NF-κB) activation. Rat bone defects confirmed accelerated inflammatory resolution and osteogenesis. These findings establish PLCL-nHA as a dual-functional scaffold that coordinates immunometabolic adaptation and tissue repair, providing a paradigm for metabolism-oriented resolution of inflammation in periodontitis and related osteolytic disorders.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Oral microbiology and periodontitis research · Bone Metabolism and Diseases · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (70)

Show source-provided references
1. P. N. Papapanou. Periodontitis: Consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. 2018, 45: S162-S170.10.1111/jcpe.12946 ↗
2. G. G. Nascimento. Burden of severe periodontitis and edentulism in 2021, with projections up to 2050: The Global Burden of Disease 2021 study. 2024, 59: 823-867.10.1111/jre.13337 ↗
3. M. A. Curtis. The role of the microbiota in periodontal disease.. 2020, 83: 14-25.10.1111/prd.12296 ↗
4. H. Hasturk. Activation and resolution of periodontal inflammation and its systemic impact.. 2015, 69: 255-273.10.1111/prd.12105 ↗
5. D. P. Lin. Interleukin-17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6/TBK1–JNK/NF- κ B pathways. 2015, 144: 472-485.10.1111/imm.12395 ↗
6. W. Y. Pan. The cytokine network involved in the host immune response to periodontitis. 2019, 11: 30.10.1038/s41368-019-0064-z ↗
7. I. Luchian. The role of matrix metalloproteinases (MMP-8, MMP-9, MMP-13) in periodontal and peri-implant pathological processes. 2022, 23: 1806.10.3390/ijms23031806 ↗
9. W. H. Hiatt. Microscopic examination of the periodontium following human bone and marrow allograft, autograft and nongraft periodontal regenerative procedures.. 1978, 49: 495-512.10.1902/jop.1978.49.10.495 ↗
10. K. Jepsen. Complications and treatment errors related to regenerative periodontal surgery.. 2023, 92: 120-134.10.1111/prd.12504 ↗
11. J. L. Gong. Polydopamine-mediated immunomodulatory patch for diabetic periodontal tissue regeneration assisted by metformin-ZIF system. 2023, 17: 16573-16586.10.1021/acsnano.3c02407 ↗
12. Y. J. Huang. Role of periodontal ligament fibroblasts in periodontitis: Pathological mechanisms and therapeutic potential. 2024, 22: 1136.10.1186/s12967-024-05944-8 ↗
13. S. T. Gao. Multifunctional injectable bioadhesive with toll-like receptor 4 and myeloid differentiation factor 2 antagonistic anti-inflammatory potential for periodontal regeneration. 2025, 19: 7098-7116.10.1021/acsnano.4c15922 ↗
14. S. Watanabe. The role of macrophages in the resolution of inflammation. 2019, 129: 2619-2628.10.1172/JCI124615 ↗
15. Y. Yu. Injectable nanocomposite hydrogels with strong antibacterial, osteoinductive, and ROS-scavenging capabilities for periodontitis treatment. 2024, 16: 14421-14433.10.1021/acsami.3c16577 ↗
16. D. K. Deng. Biotin-avidin system-based delivery enhances the therapeutic performance of MSC-derived exosomes. 2023, 17: 8530-8550.10.1021/acsnano.3c00839 ↗
17. Y. Wang. Adhesive and injectable hydrogel microspheres for NRF2-mediated periodontal bone regeneration. 2025, 17: 7.10.1038/s41368-024-00340-w ↗
18. Y. B. Yu. Recent advances in thermo-sensitive hydrogels for drug delivery. 2021, 9: 2979-2992.10.1039/D0TB02877K ↗
19. T. G. van Tienen. Tissue ingrowth and degradation of two biodegradable porous polymers with different porosities and pore sizes. 2002, 23: 1731-1738.10.1016/S0142-9612(01)00280-0 ↗
20. W. W. Shi. Lactic acid induces transcriptional repression of macrophage inflammatory response via histone acetylation. 2024, 43: 113746.10.1016/j.celrep.2024.113746 ↗
21. S. H. Chen. The emerging role of lactate in tumor microenvironment and its clinical relevance. 2024, 590: 216837.10.1016/j.canlet.2024.216837 ↗
22. L. Ma. Effect of Er:YAG Pulsed laser-deposited hydroxyapatite film on titanium implants on M2 macrophage polarization in vitro and osteogenesis in vivo . 2024, 25: 349.10.3390/ijms25010349 ↗
23. L. L. Shang. Immunomodulatory properties: The accelerant of hydroxyapatite-based materials for bone regeneration. 2022, 28: 377-392.10.1089/ten.tec.2022.00111112 ↗
24. H. Z. Xu. Restoration of critical defects in the rabbit mandible using osteoblasts and vascular endothelial cells co-cultured with vascular stent-loaded nano-composite scaffolds. 2021, 124: 104831.10.1016/j.jmbbm.2021.104831 ↗
25. D. D. Wang. PCLLA-nanoHA bone substitute promotes M2 macrophage polarization and improves alveolar bone repair in diabetic environments. 2023, 14: 536.10.3390/jfb14110536 ↗
26. C. P. Yan. 3D-printed bone regeneration scaffolds modulate bone metabolic homeostasis through vascularization for osteoporotic bone defects.. 2024, 311: 122699..10.1016/j.biomaterials.2024.122699 ↗
27. J. X. Deng. Wettability regulation of membranes based on biodegradable aliphatic polyester. 2024, 711: 123199.10.1016/j.memsci.2024.123199 ↗
28. L. C. Xu. Effects of surface wettability and contact time on protein adhesion to biomaterial surfaces. 2007, 28: 3273-3283.10.1016/j.biomaterials.2007.03.032 ↗
29. L. J. Hao. Directing the fate of human and mouse mesenchymal stem cells by hydroxyl-methyl mixed self-assembled monolayers with varying wettability. 2014, 2: 4794-4801.10.1039/C4TB00597J ↗
31. C. M. Agrawal. Technique to control pH in vicinity of biodegrading PLA-PGA implants. 1997, 38: 105-114.10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U ↗
33. M. Arce. A reappraisal of microbiome dysbiosis during experimental periodontitis. 2022, 37: 180-195.10.1111/omi.12382 ↗
34. A. A. Ribeiro. Oral biofilm dysbiosis during experimental periodontitis. 2022, 37: 256-265.10.1111/omi.12389 ↗
36. A. Basic. Microbial metabolites in the pathogenesis of periodontal diseases: A narrative review. 2023, 4: 1210200.10.3389/froh.2023.1210200 ↗
37. E. A. Ross. Macrophages: The good, the bad, and the gluttony. 2021, 12: 708186.10.3389/fimmu.2021.708186 ↗
38. Z. H. Xiao. Bone augmentation of maxillary sinus floor elevation with hydroxyapatite/ poly(lactide-co-caprolactone) composites. 2025, 30: 100624.10.1016/j.mtnano.2025.100624 ↗
39. P. Kazimierczak. The chitosan/agarose/NanoHA bone scaffold-induced M2 macrophage polarization and its effect on osteogenic differentiation in vitro . 2021, 22: 1109.10.3390/ijms22031109 ↗
40. N. N. Han. Regulation of the host immune microenvironment in periodontitis and periodontal bone remodeling. 2023, 24: 3158.10.3390/ijms24043158 ↗
41. H. Liu. Macrophage functional phenotype can be consecutively and reversibly shifted to adapt to microenvironmental changes. 2015, 8: 3044-3053.
42. Y. H. Yang. Autophagy and its significance in periodontal disease. 2021, 56: 18-26.10.1111/jre.12810 ↗
43. L. L. Liu. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways. 2020, 21: 32.10.1186/s12865-020-00355-y ↗
44. A. El-Kenawi. Inflammation, ROS, and mutagenesis. 2017, 32: 727-729.10.1016/j.ccell.2017.11.015 ↗
45. L. R. Chen. The hybrid of Cu─TCPP@Mn 3 O 4 for inflammation relief by ROS scavenging and O 2 production: An efficient strategy for antiviral therapy. 2024, 20: 2306095.10.1002/smll.202306095 ↗
46. A. Lao. Functionalized metal-organic framework-modified hydrogel that breaks the vicious cycle of inflammation and ROS for repairing of diabetic bone defects. 2023, 19: 2206919.10.1002/smll.202206919 ↗
47. E. L. Mills. Repurposing mitochondria from ATP production to ROS generation drives a pro-inflammatory phenotype in macrophages that depends on succinate oxidation by complex II. 2016, 167: 457-470.e13.10.1016/j.cell.2016.08.064 ↗
48. L. M. Du. IGF-2 preprograms maturing macrophages to acquire oxidative phosphorylation-dependent anti-inflammatory properties. 2019, 29: 1363-1375.e8.10.1016/j.cmet.2019.01.006 ↗
49. X. D. Sun. Mitochondrial calcium uniporter regulator 1 (MCUR1) relieves mitochondrial damage induced by lipopolysaccharide by mediating mitochondrial Ca 2+ homeostasis in bovine mammary epithelial cells. 2023, 71: 7278-7288.10.1021/acs.jafc.2c07494 ↗
50. X. L. Wang. Salidroside regulates mitochondrial homeostasis after polarization of RAW264.7 macrophages. 2023, 81: 85-92.10.1097/FJC.0000000000001362 ↗
51. M. Y. Li. Metabolism, metabolites, and macrophages in cancer. 2023, 16: 80.10.1186/s13045-023-01478-6 ↗
52. J. P. Auger. Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. 2024, 629: 184-192.10.1038/s41586-024-07282-7 ↗
53. A. P. West. Mitochondrial DNA stress primes the antiviral innate immune response. 2015, 520: 553-557.10.1038/nature14156 ↗
54. V. Zecchini. Fumarate induces vesicular release of mtDNA to drive innate immunity. 2023, 615: 499-506.10.1038/s41586-023-05770-w ↗
55. D. Y. Zhang. Mitochondrial DNA leakage promotes persistent pancreatic acinar cell injury in acute pancreatitis via the cGAS–STING–NF-κB pathway. 2025, 48: 1420-1437.10.1007/s10753-024-02132-0 ↗
56. L. A. J. O’Neill. Itaconate: The poster child of metabolic reprogramming in macrophage function. 2019, 19: 273-281.10.1038/s41577-019-0128-5 ↗
57. S. K. Biswas. Orchestration of metabolism by macrophages. 2012, 15: 432-437.10.1016/j.cmet.2011.11.013 ↗
58. O. Kolliniati. Metabolic regulation of macrophage activation. 2022, 14: 51-68.10.1159/000516780 ↗
59. H. C. Zhou. Lactic acid in macrophage polarization: The significant role in inflammation and cancer. 2022, 41: 4-18.10.1080/08830185.2021.1955876 ↗
60. O. R. Mahon. Nano-particle mediated M2 macrophage polarization enhances bone formation and MSC osteogenesis in an IL-10 dependent manner. 2020, 239: 119833.10.1016/j.biomaterials.2020.119833 ↗
61. L. C. Shanley. Macrophage metabolic profile is altered by hydroxyapatite particle size. 2023, 160: 311-321.10.1016/j.actbio.2023.01.058 ↗
62. T. Yoshitomi. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries. 2014, 3: 1149-1161.10.1002/adhm.201300576 ↗
63. P. Cao. A modified intrabony defect model of periodontitis in rat. 2025, 31: 2261-2272.10.1111/odi.15284 ↗
64. G. Nuerlan. Mitochondria replenishment enhances senescent periodontal ligament stem cell osteogenesis and facilitates bone repair. 2025, 18: 94907375.10.26599/NR.2025.94907375 ↗
65. J. Jung. Metabolism as a guiding force for immunity. 2019, 21: 85-93.10.1038/s41556-018-0217-x ↗
66. X. Zhong. Cordycepin modulates microglial M2 polarization coupled with mitochondrial metabolic reprogramming by targeting HKII and PDK2. 2024, 11: 2304687.10.1002/advs.202304687 ↗
67. Z. Y. Yang. The impact of NLRP3 inflammasome on osteoblasts and osteogenic differentiation: A literature review. 2024, 17: 2639-2653.10.2147/JIR.S457927 ↗
68. Y. Z. Hu. Human gingival mesenchymal stem cell-derived exosomes cross-regulate the Wnt/β-catenin and NF-κB signalling pathways in the periodontal inflammation microenvironment. 2023, 50: 796-806.10.1111/jcpe.13798 ↗
69. D. H. Wang. Multi-scale composite Ag–TiO 2 nanoreactor for long-lasting antibacterial and immunomodulatory therapy of periodontitis. 2025, 18: 94907527.10.26599/NR.2025.94907527 ↗
70. T. Shen. Sulfated chitosan rescues dysfunctional macrophages and accelerates wound healing in diabetic mice. 2020, 117: 192-203.10.1016/j.actbio.2020.09.035 ↗